(Q35760022)

10 August 2017

0 references

No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial (English)

1 reference

10 August 2017

main subject

ankylosing spondylitis

1 reference

1 reference

H Haibel

1

1 reference

10 August 2017

H C Brandt

2

1 reference

10 August 2017

I H Song

3

1 reference

10 August 2017

A Brandt

4

1 reference

10 August 2017

J Listing

5

1 reference

10 August 2017

M Rudwaleit

6

1 reference

10 August 2017

J Sieper

7

1 reference

10 August 2017

language of work or name

English

0 references

publication date

10 August 2006

1 reference

Annals of the Rheumatic Diseases

10 August 2017

published in

1 reference

10 August 2017

volume

66

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

419-421

1 reference

ASAS/EULAR recommendations for the management of ankylosing spondylitis

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856012

Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856012

Six months open label trial of leflunomide in active ankylosing spondylitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856012

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856012

Medication toxicity among patients with ankylosing spondylitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856012

The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: a six-month, longitudinal, observational, multicenter study.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856012

Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856012

Clinical investigation of methotrexate in the treatment of ankylosing spondylitis

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856012

Methotrexate in the treatment of ankylosing spondylitis.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856012

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856012

Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis

15 November 2018

1 reference

12 December 2020

Is methotrexate effective in ankylosing spondylitis?

1 reference

12 December 2020

Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial

1 reference

12 December 2020

Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.2006.054098

1 reference

10 August 2017

1 reference

10 August 2017

1 reference